Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model

Antimicrobial Agents and Chemotherapy
Cécile VinotLaurent Mandelbrot

Abstract

Placental transfer of the HIV integrase inhibitor raltegravir (RLT) was investigated in term human cotyledons in the maternal-to-fetal (n = 3) and fetal-to-maternal (n = 6) directions. In the maternal-to-fetal direction, the mean ± standard deviation (SD) fetal transfer rate (FTR) was 9.1% ± 1.4%, and the mean ± SD clearance index (IC), i.e., RLT FTR/antipyrine FTR, was 0.28 ± 0.05. In the fetal-to-maternal direction, the mean ± SD CI was 0.31 ± 0.09. Placental transfer of RLT was high in both directions.

References

Nov 15, 1972·American Journal of Obstetrics and Gynecology·H SchneiderJ Dancis
Jan 1, 1983·Reproduction, Nutrition, Development·J C ChallierM Nandakumaran
Aug 3, 2001·American Journal of Obstetrics and Gynecology·F ForestierL Mandelbrot
May 9, 2006·American Journal of Obstetrics and Gynecology·Laurent GavardLaurent Mandelbrot
Jun 27, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kelem KassahunLarissa A Wenning
Mar 20, 2010·The Cochrane Database of Systematic Reviews·Amy S SturtTin Tin Sint
Aug 13, 2010·Expert Opinion on Drug Metabolism & Toxicology·David M Burger
Aug 17, 2010·Expert Opinion on Investigational Drugs·Nicole Prada, Martin Markowitz
Nov 17, 2010·Antimicrobial Agents and Chemotherapy·Darren M MossAndrew Owen
Dec 2, 2010·São Paulo Medical Journal = Revista Paulista De Medicina
Mar 12, 2011·The Journal of Antimicrobial Chemotherapy·Nadine Cécile Luise ZembruskiJohanna Weiss
Mar 3, 2012·European Journal of Clinical Pharmacology·Leonardo CrociCesira Nencioni
Jun 5, 2013·AIDS Research and Human Retroviruses·Isabella NóbregaCarlos Brites
Nov 28, 2013·Journal of the International AIDS Society·Maria L EkstrandElsa Heylen
Jul 2, 2014·Antimicrobial Agents and Chemotherapy·Laurent MandelbrotGilles Peytavin
Aug 28, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·D Heather WattsUNKNOWN IMPAACT 1026s study team
Sep 12, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Emil IvanMartin P Grobusch
Feb 19, 2015·Antimicrobial Agents and Chemotherapy·Laurent MandelbrotGilles Peytavin
May 7, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maren I BlonkUNKNOWN PANNA Network
Jul 23, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Laurent MandelbrotUNKNOWN ANRS-EPF Study Group
Aug 4, 2015·The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale·I BoucoiranM Boucher

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

© 2021 Meta ULC. All rights reserved